Trexquant Investment LP

Position in JNJ — Johnson & Johnson

CIK 1633445 STAMFORD, CT

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$48,635,762

-$21,849,000 QoQ

Shares Held

191,502

-33.6% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.30%

of 13F equity value

Holder Rank

#446

of 4,664 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $226,269,634 across 5 Drug Manufacturers - General names. JNJ ranks #3 (21.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	90,850	$108,968,224
2	NVO	Novo Nordisk A S	1,227,405	$58,841,795
3	JNJ	Johnson & Johnson This page	191,502	$48,635,762
4	BMY	Bristol Myers Squibb Co	164,114	$9,456,248
5	PFE	Pfizer Inc	15,266	$367,605

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$48,635,762	191,502	-33.6%	Shares	Sole	2026-08-14
2026-03-31	$70,484,762	288,352	-15.5%	Shares	Sole	2026-05-15
2025-12-31	$70,653,557	341,404	+118.0%	Shares	Sole	2026-02-17
2025-09-30	$29,043,817	156,638	+39.0%	Shares	Sole	2025-11-14
2025-06-30	$17,209,731	112,666	+17.0%	Shares	Sole	2025-08-12
2025-03-31	$15,963,592	96,259	-37.1%	Shares	Sole	2025-05-14
2023-09-30	$23,847,817	153,116	+96.5%	Shares	Sole	2023-11-13
2022-06-30	$13,835,129	77,940	+93.6%	Shares	Sole	2022-08-11
2021-09-30	$6,502,474	40,263	+147.0%	Shares	Sole	2021-11-12
2021-06-30	$2,684,932	16,298	-39.6%	Shares	Sole	2021-08-12
2020-06-30	$3,796,728	26,998	—	Shares	Sole	2020-08-07
No filing history on record for this holder in this stock.